Crave for food and cigarette are two unhealthy urges. They lead you to path of inheriting various diseases. Such detrimental habits if not controlled can lead the mankind to disastrous consequences. Medical science has found a medication to control both food and cigarette yearnings. This will help people to loose weight and quit smoking and will also curb certain other unhealthy habits.
The medical community eagerly awaits the FDA approval of Acomplia. The scientific name for accomplia is Rimonabant. Developed by the French drug maker Sanofi-Synthelabo, it is also referred to as Zimulti. It is another trademarked name given for the marketing of Rimonabant.
Acomplia works by targeting the CBI receptors and blocking the bodys ability to receive signals that tells it to smoke or eat more. It helps to normalize the EC system thus making hunger and cigarette cravings more manageable. This blocking of signals results in weight loss. It further improves the cardiovascular or metabolic risk factors in obese people and reduces their dependence on tobacco and helps them quit smoking.
Although acomplia benefits more of the obese people, still its usefulness for the...
To view and download this full PLR article, you must be logged in. Registration is completely free. Once you create your account, you will be able to browse, search & downlod from our PLR articles database of over "1,57,897+" on 1,000's of niches and 200+ categories without paying a penny. Click here to signup...
